Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Apr. 01, 2016	Sep. 25, 2015
Current assets:
Cash and cash equivalents	$ 521,202	$ 531,926
Restricted cash	5,278	2,936
Short-term investments	104,267	138,901
Accounts receivable, net of allowance for doubtful accounts of $2,665 and $1,542	102,083	101,563
Inventories	17,259	13,872
Prepaid expenses and other current assets	36,198	32,031
Total current assets	786,287	821,229
Long-term investments	268,091	321,015
Property, plant and equipment, net	416,254	403,091
Intangible assets, net	216,082	127,507
Goodwill	309,880	307,708
Deferred taxes	149,272	143,279
Other non-current assets	12,985	9,464
Total assets	2,158,851	2,133,293
Current liabilities:
Accounts payable	17,632	20,710
Accrued liabilities	158,534	169,307
Income taxes payable	0	754
Deferred revenue	22,321	18,910
Total current liabilities	198,487	209,681
Long-term deferred revenue	35,652	30,581
Other non-current liabilities	70,664	77,024
Total liabilities	304,803	317,286
Stockholders' equity:
Additional paid-in capital	0	17,571
Retained earnings	1,853,602	1,800,857
Accumulated other comprehensive (loss)	(8,342)	(11,462)
Total stockholders’ equity – Dolby Laboratories, Inc.	1,845,361	1,807,068
Controlling interest	8,687	8,939
Total stockholders’ equity	1,854,048	1,816,007
Total liabilities and stockholders’ equity	2,158,851	2,133,293
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 53,265,096 shares issued and outstanding at April 1, 2016 and 50,291,426 at September 25, 2015
Stockholders' equity:
Common stock	54	51
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 46,790,462 shares issued and outstanding at April 1, 2016 and 50,743,311 at September 25, 2015
Stockholders' equity:
Common stock	$ 47	$ 51